The FOrMe Registry (The German Focal Segmental Glomerulosclerosis and Minimal Change Disease Registry)

Status: Recruiting
Location: See all (12) locations...
Intervention Type: Other
Study Type: Observational
SUMMARY

In a monocentric, later multicentric prospective approach the FOrMe registry (The German Focal Segmental Glomerulosclerosis and Minimal Change Disease Registry) aims to generate a longitudinal cohort of 150 pediatric cases of idiopathic nephrotic syndrome and 350 adult cases of biopsy-proven Minimal Change Disease (MCD) or Focal and Segmental Glomerular Sclerosis (FSGS) over 10 years. The registry will provide a repository for biomaterials such as blood samples, DNA, urine, feces, and tissue biopsies that will be accessible to collaborators to facilitate future research on pathogenesis, diagnostics, and treatment.

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:

• written informed consent

• 17 or less years of age

• idiopathic nephrotic syndrome

• written informed consent

• older or equal to 18 years of age

• biopsy-proven primary or secondary FSGS or MCD or biopsy-proven recurrence of disease in kidney transplant.

Locations
Other Locations
Germany
Uniklinik RWTH Aachen
NOT_YET_RECRUITING
Aachen
Charité University Hospital
RECRUITING
Berlin
Kindernierenzentrum Bonn
RECRUITING
Bonn
University Hospital of Cologne
RECRUITING
Cologne
Kindernephrologie Dachau
RECRUITING
Dachau
University Hospital Erlangen
NOT_YET_RECRUITING
Erlangen
University Hospital Essen
RECRUITING
Essen
University Hospital Heidelberg
RECRUITING
Heidelberg
Klinikum St. Georg
RECRUITING
Leipzig
University Hospital Marburg
RECRUITING
Marburg
University Hospital Münster
RECRUITING
Münster
Klinikum Stuttgart
RECRUITING
Stuttgart
Contact Information
Primary
Paul T Brinkkoetter, MD
paul.brinkkoetter@uk-koeln.de
+49-221-478-4480
Backup
Linus A Voelker, MD
linus.voelker@uk-koeln.de
+49-221-478-4480
Time Frame
Start Date: 2018-04-01
Estimated Completion Date: 2033-03-31
Participants
Target number of participants: 500
Treatments
A - Pediatric Cohort
Pediatric patients until 18 years of age presenting with or diagnosed with idiopathic nephrotic syndrome or a biopsy-proven diagnosis of MCD or FSGS.
B -Adult Cohort
Adult patients 18 years and above with a biopsy-proven diagnosis of primary or secondary FSGS or MCD.
Sponsors
Collaborators: Medical Faculty and the Faculty of Natural Sciences of the University of Cologne, German Research Foundation, Cluster of Excellence on Cellular Stress Responses in Ageing-Associated Diseases, Cologne Center for Genomics
Leads: Prof. Dr. Paul Brinkkoetter

This content was sourced from clinicaltrials.gov